JanOne Inc. (JAN)
| Market Cap | 17.13M |
| Revenue (ttm) | 38.69M |
| Net Income (ttm) | -8.25M |
| Shares Out | 2.41M |
| EPS (ttm) | -4.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 61,628 |
| Open | 6.22 |
| Previous Close | 6.27 |
| Day's Range | 6.02 - 6.34 |
| 52-Week Range | 3.49 - 31.83 |
| Beta | 1.56 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 8, 2021 |
About JAN
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain. It operates in three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral art...
Financial Performance
In 2020, JanOne's revenue was $33.87 million, a decrease of -3.50% compared to the previous year's $35.10 million. Losses were -$8.50 million, -28.97% less than in 2019.
Financial StatementsNews
JanOne Expects Revenue Push From ARCA Recycling's Appliance Replacement Contracts
JanOne Inc (NASDAQ: JAN) stated subsidiary ARCA Recycling, Inc. had seen growth in its appliance replacement programs throughout the past 12 months, with the addition of new contracts signed this year t...
ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Pus...
MINNEAPOLIS, Oct. 19, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), has seen major growth in its appliance replacement programs throughout the past 1...
ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts T...
MINNEAPOLIS, Oct. 12, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), recently opened a new recycling facility in Grand Rapids, Michigan to support its...
ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value o...
MINNEAPOLIS, Oct. 7, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), was recently awarded multiple contracts to operate appliance recycling programs in...
Janone Subsidiary Opens New Recycling Center In Pennsauken, New Jersey
Janone Inc (NASDAQ: JAN), subsidiary ARCA Recycling, Inc., opened a new appliance recycling center in Pennsauken, New Jersey, to process appliances collected through new programs with multiple electric ...
ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs
MINNEAPOLIS, Sept. 30, 2021 /PRNewswire/ -- ARCA Recycling, Inc., a wholly owned subsidiary of JanOne Inc. (NASDAQ: JAN), opened a new appliance recycling center last month in Pennsauken, New Jersey.
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101
LAS VEGAS, Sept. 28, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in conjunction with its continuing fo...
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Pati...
LAS VEGAS, July 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites
LAS VEGAS, June 23, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
LAS VEGAS, June 22, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives
LAS VEGAS, June 10, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101
LAS VEGAS, June 8, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propertie...
JanOne Announces Closing of $6.0 Million Common Stock Offering
LAS VEGAS, Feb. 2, 2021 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propertie...
JanOne Prices $6.0 Million Common Stock Offering
LAS VEGAS, Jan. 29, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properti...
Why JanOne's Stock Are Trading Higher Today
JanOne (NASDAQ: JAN) shares are trading higher as speculative retail trading, particularly among the Reddit community, continues to drive volatility in the stock. JanOne is focused on reducing opioid ad...
JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up Fever
JanOne (JAN) stock is soaring higher Thursday morning as it joins other stocks being boosted by Reddit and other social media users. The post JAN Stock: JanOne Shares Skyrocket as Part of Reddit Run-Up ...
JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Ar...
LAS VEGAS, Sept. 22, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving propert...
JanOne Announces Strategic Plan to Divest its Legacy Businesses
LAS VEGAS, Sept. 16, 2020 /PRNewswire/ -- JanOne Inc.
JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential Covid-19 Clini...
LAS VEGAS, Aug. 28, 2020 /PRNewswire/ -- JanOne Inc.
JanOne Advances its Potential Peripheral Artery Disease and Covid-19 Vascular Inflammation Treatment Towards Trial Re...
LAS VEGAS, Aug. 26, 2020 /PRNewswire/ -- JanOne Inc.
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Pot...
LAS VEGAS, Aug. 21, 2020 /PRNewswire/ -- JanOne Inc.
JanOne to Present at The LD 500 Virtual Conference
LAS VEGAS, Aug. 19, 2020 /PRNewswire/ -- JanOne Inc.
JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcomin...
LAS VEGAS, Aug. 11, 2020 /PRNewswire/ -- JanOne Inc.